Vinva Investment Management Ltd increased its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 9.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,767 shares of the technology company’s stock after purchasing an additional 556 shares during the quarter. Vinva Investment Management Ltd’s holdings in Veeva Systems were worth $1,427,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. Fiduciary Trust Co lifted its holdings in shares of Veeva Systems by 0.9% during the 3rd quarter. Fiduciary Trust Co now owns 8,289 shares of the technology company’s stock valued at $1,740,000 after buying an additional 71 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Veeva Systems by 17.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 77,653 shares of the technology company’s stock valued at $16,297,000 after acquiring an additional 11,433 shares during the last quarter. Townsquare Capital LLC lifted its holdings in Veeva Systems by 35.7% in the third quarter. Townsquare Capital LLC now owns 4,762 shares of the technology company’s stock valued at $999,000 after acquiring an additional 1,253 shares during the period. Brooklyn Investment Group purchased a new position in Veeva Systems in the third quarter worth about $68,000. Finally, D.A. Davidson & CO. boosted its position in Veeva Systems by 2.5% in the third quarter. D.A. Davidson & CO. now owns 5,630 shares of the technology company’s stock worth $1,182,000 after purchasing an additional 136 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.
Insider Activity at Veeva Systems
In related news, insider Thomas D. Schwenger sold 1,126 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the transaction, the insider now owns 27,013 shares in the company, valued at $6,483,390.13. The trade was a 4.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 10.50% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on Veeva Systems
Veeva Systems Stock Up 0.5 %
Shares of VEEV opened at $227.94 on Friday. The business has a fifty day moving average of $215.71 and a 200 day moving average of $202.00. The company has a market cap of $36.91 billion, a PE ratio of 60.78, a P/E/G ratio of 2.20 and a beta of 0.81. Veeva Systems Inc. has a 52-week low of $165.12 and a 52-week high of $240.68.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its earnings results on Wednesday, August 28th. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.03. Veeva Systems had a net margin of 23.91% and a return on equity of 13.30%. The firm had revenue of $676.18 million during the quarter, compared to analyst estimates of $667.21 million. As a group, research analysts anticipate that Veeva Systems Inc. will post 4.19 earnings per share for the current fiscal year.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What is MarketRankā¢? How to Use it
- 3 Penny Stocks Ready to Break Out in 2025
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.